10 Health Care Stocks With Whale Alerts In Today’s Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums…
Insiders Buying Dorian LPG And 2 Other Stocks
Although U.S. stocks closed lower on Tuesday, there were a few notable insider trades.
Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday’s Mid-Day Session
Shares of RxSight, Inc. (NASDAQ: RXST) rose sharply during Monday’s session after the company issued preliminary FY23 and FY24 revenue guidance above estimates.
Also, Needham maintained a Buy rating on the stock and raised its price target from $35 to $41.
Needham Maintains Buy Rating for Avadel Pharmaceuticals: Here’s What You Need To Know
Needham has decided to maintain its Buy rating of Avadel Pharmaceuticals (NASDAQ:AVDL) and raise its price target from…
Avadel Pharmaceuticals Sees Robust Uptake For Its Newly Approved Sleep Disorder Drug
Avadel Pharmaceuticals plc (NASDAQ: AVDL) recognized $7.0 million in net product revenue for Q3.
Roblox, Under Armour, GoPro, Nuvei And Other Big Stocks Moving Higher On Wednesday
U.S. stocks traded mostly lower, with the Nasdaq Composite falling around 20 points on Wednesday. Here are some big stocks recording gains in today’s session.
Earnings Scheduled For November 8, 2023
Companies Reporting Before The Bell
• Flex LNG (NYSE:FLNG) is estimated to report earnings for its third quarter.
Preview: Avadel Pharmaceuticals’s Earnings
Avadel Pharmaceuticals (NASDAQ:AVDL) is set to give its latest quarterly earnings report on Wednesday, 2023-11-08. Here’s what investors…
Avadel Pharmaceuticals Announces Data Supporting Clinical Profile For LUMRYZ For Extended-Release Oral Suspension At World Sleep 2023
– 17 abstracts accepted, including new and encore data emphasizing clinical benefit and patient preference for a once-at-bedtime narcolepsy treatment option – – Company to host symposium on October 24 with
Where Avadel Pharmaceuticals Stands With Analysts
Within the last quarter, Avadel Pharmaceuticals (NASDAQ:AVDL) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat…